In chronic autoimmune diseases such as systemic lupus erythematodus (SLE), surplus activation of CAMK is associated with disruptions of the balance of TREGs and TH17cells and suppression of IL-2 production52–54. The gene discussed is IL2; the disease is systemic lupus erythematosus.